Macro...
Cons:
- Inquisition on Pharmas start up again
- Spending on prescription drugs topped $954 billion in 2011 in Europe and North America but have been on a decline since then.
- New tech... Gene, Immuno and nano theraphy etc
Pro:
- Although somewhat wayning in Europe and North America in recent years, the ageing and long living but largely unhealthy population should increase demand.
- Growth in pharma use in emerging countries has outpaced in Europe and North America.
- The best-selling drug patents have expired or about to expire to name a few - Lipitor, Humira, Enbrel, Remicade, Abilify, Nexium...
Macro... Cons: - Inquisition on Pharmas start up again -...
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.97 |
Change
-0.010(0.20%) |
Mkt cap ! $418.5M | |||
| Open | High | Low | Value | Volume |
| $4.98 | $4.99 | $4.84 | $174.9K | 35.47K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 1682 | $4.95 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.97 | 588 | 6 |
View Market Depth
| Last trade - 10.56am 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$5.01 |
Change
-0.010 ( 0.42 %) |
||||
| Open | High | Low | Volume | ||
| $4.98 | $5.03 | $4.84 | 13578 | ||
| Last updated 11.14am 30/05/2024 ? | |||||
| MYX (ASX) Chart |